M&A Deal Summary |
|
|---|---|
| Date | 2021-09-01 |
| Target | PDS Life Sciences |
| Sector | Software |
| Buyer(s) | Instem |
| Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1969 |
| Sector | Information Technology |
| Employees | 480 |
| Revenue | 28M GBP (2020) |
Instem is a provider of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem was founded in 1969 and is based in Stone, the United Kingdom.
| DEAL STATS | # |
|---|---|
| Overall | 9 of 9 |
| Sector (Software) | 4 of 4 |
| Type (Add-on Acquisition) | 9 of 9 |
| Country (Switzerland) | 1 of 1 |
| Year (2021) | 3 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-03-22 |
d-wise
Morrisville, North Carolina, United States Founded in 2003, d-wise is a clinical trial technology domain expert that advises on and builds clinical trial analysis and data anonymization solutions, leveraging open-source and cloud technologies. For 19 of the top 20 global pharmaceutical companies, d-wise has made a significant impact in creating operational and clinical data efficiencies that have accelerated clinical trial analysis and regulatory submissions. d-wise supports its global customer community through its U.S. headquarters based in Research Triangle Park, North Carolina, along with an office location in Manchester, United Kingdom. |
Buy | - |
